557 related articles for article (PubMed ID: 26786720)
1. Improving T-cell assays for diagnosis of latent TB infection: Confirmation of the potential role of testing Interleukin-2 release in Iranian patients.
Mamishi S; Pourakbari B; Shams H; Marjani M; Mahmoudi S
Allergol Immunopathol (Madr); 2016; 44(4):314-21. PubMed ID: 26786720
[TBL] [Abstract][Full Text] [Related]
2. [Evolution of IGRA researches].
Ariga H; Harada N
Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
[TBL] [Abstract][Full Text] [Related]
3. Potential Role for Mycobacterium tuberculosis Specific IL-2 and IFN-γ Responses in Discriminating between Latent Infection and Active Disease after Long-Term Stimulation.
Sun Q; Wei W; Sha W
PLoS One; 2016; 11(12):e0166501. PubMed ID: 28033330
[TBL] [Abstract][Full Text] [Related]
4. Novel T-cell assays for the discrimination of active and latent tuberculosis infection: the diagnostic value of PPE family.
Pourakbari B; Mamishi S; Marjani M; Rasulinejad M; Mariotti S; Mahmoudi S
Mol Diagn Ther; 2015 Oct; 19(5):309-16. PubMed ID: 26245995
[TBL] [Abstract][Full Text] [Related]
5. Identification of mycobacterial bacterioferritin B for immune screening of tuberculosis and latent tuberculosis infection.
Yang X; Wu JB; Liu Y; Xiong Y; Ji P; Wang SJ; Chen Y; Zhao GP; Lu SH; Wang Y
Tuberculosis (Edinb); 2017 Dec; 107():119-125. PubMed ID: 29050758
[TBL] [Abstract][Full Text] [Related]
6. Involvement of methylated HBHA expressed from Mycobacterium smegmatis in an IFN-γ release assay to aid discrimination between latent infection and active tuberculosis in BCG-vaccinated populations.
Wen HL; Li CL; Li G; Lu YH; Li HC; Li T; Zhao HM; Wu K; Lowrie DB; Lv JX; Lu SH; Fan XY
Eur J Clin Microbiol Infect Dis; 2017 Aug; 36(8):1415-1423. PubMed ID: 28429162
[TBL] [Abstract][Full Text] [Related]
7. Discrimination between active and latent tuberculosis based on ratio of antigen-specific to mitogen-induced IP-10 production.
Jeong YH; Hur YG; Lee H; Kim S; Cho JE; Chang J; Shin SJ; Lee H; Kang YA; Cho SN; Ha SJ
J Clin Microbiol; 2015 Feb; 53(2):504-10. PubMed ID: 25428147
[TBL] [Abstract][Full Text] [Related]
8. Mycobacteria-Specific Cytokine Responses Detect Tuberculosis Infection and Distinguish Latent from Active Tuberculosis.
Tebruegge M; Dutta B; Donath S; Ritz N; Forbes B; Camacho-Badilla K; Clifford V; Zufferey C; Robins-Browne R; Hanekom W; Graham SM; Connell T; Curtis N
Am J Respir Crit Care Med; 2015 Aug; 192(4):485-99. PubMed ID: 26030187
[TBL] [Abstract][Full Text] [Related]
9. Measurement of phenotype and absolute number of circulating heparin-binding hemagglutinin, ESAT-6 and CFP-10, and purified protein derivative antigen-specific CD4 T cells can discriminate active from latent tuberculosis infection.
Hutchinson P; Barkham TM; Tang W; Kemeny DM; Chee CB; Wang YT
Clin Vaccine Immunol; 2015 Feb; 22(2):200-12. PubMed ID: 25520147
[TBL] [Abstract][Full Text] [Related]
10. Immunological diagnosis of tuberculosis based on recombinant antigens ESAT-6 and CFP-10 in children from an endemic area in northeast Brazil.
Van-Lume DS; De Souza JR; Cabral MM; Rego JC; Balbino V; Saad MH; Schindler HC; Abath FG; Montenegro SM
Scand J Immunol; 2010 Nov; 72(5):460-8. PubMed ID: 21039742
[TBL] [Abstract][Full Text] [Related]
11. Ethnicity-tailored novel set of ESAT-6 peptides for differentiating active and latent tuberculosis.
Singh SB; Biswas D; Rawat J; Sindhwani G; Patras A; Devrani S; Sarkar P; Mitra S; Gupta SK
Tuberculosis (Edinb); 2013 Nov; 93(6):618-24. PubMed ID: 24011630
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers for discrimination between latent tuberculosis infection and active tuberculosis disease.
Won EJ; Choi JH; Cho YN; Jin HM; Kee HJ; Park YW; Kwon YS; Kee SJ
J Infect; 2017 Mar; 74(3):281-293. PubMed ID: 27871809
[TBL] [Abstract][Full Text] [Related]
13. The meta-analysis for ideal cytokines to distinguish the latent and active TB infection.
Wei Z; Li Y; Wei C; Li Y; Xu H; Wu Y; Jia Y; Guo R; Jia J; Qi X; Li Z; Gao X
BMC Pulm Med; 2020 Sep; 20(1):248. PubMed ID: 32948170
[TBL] [Abstract][Full Text] [Related]
14. Novel M. tuberculosis specific IL-2 ELISpot assay discriminates adult patients with active or latent tuberculosis.
Della Bella C; Spinicci M; Grassi A; Bartalesi F; Benagiano M; Truthmann K; Tapinassi S; Troilo A; D'Elios S; Alnwaisri H; Shuralev E; Singh M; Bartoloni A; D'Elios MM
PLoS One; 2018; 13(6):e0197825. PubMed ID: 29856871
[TBL] [Abstract][Full Text] [Related]
15. Using the TBAg/PHA ratio in the T-SPOT(®).TB assay to distinguish TB disease from LTBI in an endemic area.
Wang F; Hou HY; Wu SJ; Zhu Q; Huang M; Yin B; Huang J; Pan YY; Mao L; Sun ZY
Int J Tuberc Lung Dis; 2016 Apr; 20(4):487-93. PubMed ID: 26970158
[TBL] [Abstract][Full Text] [Related]
16. Potential role of M. tuberculosis specific IFN-γ and IL-2 ELISPOT assays in discriminating children with active or latent tuberculosis.
Chiappini E; Della Bella C; Bonsignori F; Sollai S; Amedei A; Galli L; Niccolai E; Del Prete G; Singh M; D'Elios MM; de Martino M
PLoS One; 2012; 7(9):e46041. PubMed ID: 23029377
[TBL] [Abstract][Full Text] [Related]
17. Utility of interferon gamma/tumor necrosis factor alpha FluoroSpot assay in differentiation between active tuberculosis and latent tuberculosis infection: a pilot study.
Zhang L; Wan S; Zhou Z; Zhang Y; Liu X
BMC Infect Dis; 2021 Jul; 21(1):651. PubMed ID: 34225667
[TBL] [Abstract][Full Text] [Related]
18. Contribution of interferon-γ release assays (IGRAs) to the diagnosis of latent tuberculosis infection after renal transplantation.
Hadaya K; Bridevaux PO; Roux-Lombard P; Delort A; Saudan P; Martin PY; Janssens JP
Transplantation; 2013 Jun; 95(12):1485-90. PubMed ID: 23694948
[TBL] [Abstract][Full Text] [Related]
19. Interferon gamma release assays: principles and practice.
Lalvani A; Pareek M
Enferm Infecc Microbiol Clin; 2010 Apr; 28(4):245-52. PubMed ID: 19783328
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of IL-2, IL-10, IL-17 and IP-10 as potent discriminative markers for active tuberculosis among pulmonary tuberculosis suspects.
You E; Kim MH; Lee WI; Kang SY
Tuberculosis (Edinb); 2016 Jul; 99():100-108. PubMed ID: 27450011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
